Actos, Avandia or Neither? The Diabetes Drug Debate (Video)

Sun, 08 Nov 2009 GMT

NEWS YOU CAN TRUST

Browser Preferences
Add to Favorites

Main Menu

Home

- - - - - Hot Topics - - - - -

Bird Flu

Drug Safety

Stem Cell Research

- - - - - - - - - - - - - - - - -

*Diseases & Conditions

Allergies

Asthma

*Cancer

*Cardiovascul

Diabetes

HIV

Neurologic

Obesity

Pain

Parenting

Public Health & Safety

Senior Care

*Sexual Health

Women's Health

World Health

- - - - - - - - - - - - - - - -

Web Links

XML News Feeds

HEALTH NEWS

Actos, Avandia or Neither? The Diabetes Drug Debate (Video)

14 October, 2007 01:08 GMT

The US Food and Drug Administration recommended earlier this year that Avandia, the widely used diabetes pill manufactured by GlaxoSmithKline, be permitted to remain on the market despite indications that it might contribute to heart attacks in some users. Studies have also linked Actos to increased risk of heart failure. Listen to the discussion.

Antidiabetic Drug Fends Off Heart Attacks (16 Nov 2005)

Avandia May Cut Diabetes Risk in Half (15 Sep 2006)

Study Results Fuel Avandia Safety Controversy (12 Dec 2007)

FDA Panel Votes to Keep Avandia on Market Despite Risks (31 Jul 2007)

Metabolic Syndrome Worsens Heart-Attack Outcomes (23 May 2005)

Kidney Failure Rates Down, But Disparities Persist (11 Oct 2005)